BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31817867)

  • 1. Comparison of In Vitro and In Vivo Results Using the GastroDuo and the Salivary Tracer Technique: Immediate Release Dosage Forms under Fasting Conditions.
    Sager M; Schick P; Mischek M; Schulze C; Hasan M; Kromrey ML; Benameur H; Wendler M; Tzvetkov MV; Weitschies W; Koziolek M
    Pharmaceutics; 2019 Dec; 11(12):. PubMed ID: 31817867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the GastroDuo to study the interplay of drug release and gastric emptying in case of immediate release Aspirin formulations.
    Schick P; Sager M; Voelker M; Weitschies W; Koziolek M
    Eur J Pharm Biopharm; 2020 Jun; 151():9-17. PubMed ID: 32268191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Application of MRI and the Salivary Tracer Technique to Determine the in Vivo Disintegration Time of Immediate Release Formulation Administered to Healthy, Fasted Subjects.
    Sager M; Grimm M; Jedamzik P; Merdivan S; Kromrey ML; Hasan M; Koziolek M; Tzvetkov MV; Weitschies W
    Mol Pharm; 2019 Apr; 16(4):1782-1786. PubMed ID: 30821987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capsule shell material impacts the in vitro disintegration and dissolution behaviour of a green tea extract.
    Glube N; Moos Lv; Duchateau G
    Results Pharma Sci; 2013; 3():1-6. PubMed ID: 25755998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Coadministered Water on the In Vivo Performance of Oral Formulations Containing N-Acetylcysteine: An In Vitro Approach Using the Dynamic Open Flow-Through Test Apparatus.
    Sager M; Schneider F; Jedamzik P; Wiedmann M; Schremmer E; Koziolek M; Weitschies W
    Mol Pharm; 2017 Dec; 14(12):4272-4280. PubMed ID: 29064257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the GastroDuo as an in Vitro Dissolution Tool To Simulate the Gastric Emptying of the Postprandial Stomach.
    Schick P; Sager M; Wegner F; Wiedmann M; Schapperer E; Weitschies W; Koziolek M
    Mol Pharm; 2019 Nov; 16(11):4651-4660. PubMed ID: 31593480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Capsule-in-Capsule Combinations on In Vivo Disintegration in Human Volunteers: A Combined Imaging and Salivary Tracer Study.
    Rump A; Weiss FN; Schulz L; Kromrey ML; Scheuch E; Tzvetkov MV; White T; Durkee S; Judge KW; Jannin V; Bellamine A; Weitschies W; Grimm M
    Pharmaceutics; 2021 Nov; 13(12):. PubMed ID: 34959284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of near zero-order release dosage forms using three-dimensional printing (3-DP) technology.
    Wang CC; Tejwani Motwani MR; Roach WJ; Kay JL; Yoo J; Surprenant HL; Monkhouse DC; Pryor TJ
    Drug Dev Ind Pharm; 2006 Mar; 32(3):367-76. PubMed ID: 16556541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo characterization of enTRinsic™ drug delivery technology capsule after intake in fed state: A cross-validation approach using salivary tracer technique in comparison to MRI.
    Sager M; Grimm M; Aude P; Schick P; Merdivan S; Hasan M; Kromrey ML; Sivert A; Benameur H; Koziolek M; Tzvetkov MV; Weitschies W
    J Control Release; 2019 Nov; 313():24-32. PubMed ID: 31626859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the in vivo disintegration of solid dosage forms of a bile acid sequestrant in dogs using gamma-scintigraphy and correlation to in vitro disintegration.
    Hussain MA; Chang RK; Sandefer E; Page RC; Digenis GA
    Pharm Res; 2003 Mar; 20(3):460-4. PubMed ID: 12669969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the Dynamic Gastric Model as a tool for investigating fed and fasted sensitivities of low polymer content hydrophilic matrix formulations.
    Mason LM; Chessa S; Huatan H; Storey DE; Gupta P; Burley J; Melia CD
    Int J Pharm; 2016 Aug; 510(1):210-20. PubMed ID: 27311354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteric Hard Capsules for Targeting the Small Intestine: Positive Correlation between In Vitro Disintegration and Dissolution Times.
    Fu M; Al-Gousous J; Blechar JA; Langguth P
    Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32028731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
    Franek F; Holm P; Larsen F; Steffansen B
    Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erosion characteristics of an erodible tablet incorporated in a time-delayed capsule device.
    McConville JT; Ross AC; Florence AJ; Stevens HN
    Drug Dev Ind Pharm; 2005 Jan; 31(1):79-89. PubMed ID: 15704859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Pharmacokinetics of a Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and an Immediate-release Pregabalin Capsule in Healthy Male Volunteers.
    Kim TE; Jeon JY; Gu N; Chang Kwon M; Kim MG
    Clin Ther; 2018 Dec; 40(12):2112-2124. PubMed ID: 30497798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
    Swanson JM; Wigal SB; Wigal T; Sonuga-Barke E; Greenhill LL; Biederman J; Kollins S; Nguyen AS; DeCory HH; Hirshe Dirksen SJ; Hatch SJ;
    Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The shell dissolution of various empty hard capsules.
    Chiwele I; Jones BE; Podczeck F
    Chem Pharm Bull (Tokyo); 2000 Jul; 48(7):951-6. PubMed ID: 10923822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus.
    Garbacz G; Cadé D; Benameur H; Weitschies W
    Eur J Pharm Sci; 2014 Jun; 57():264-72. PubMed ID: 24021609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the human in vivo performance of different oral capsule shell types using a novel in vitro dynamic gastric model.
    Vardakou M; Mercuri A; Naylor TA; Rizzo D; Butler JM; Connolly PC; Wickham MS; Faulks RM
    Int J Pharm; 2011 Oct; 419(1-2):192-9. PubMed ID: 21843611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.